February 2, 2026 · Form 4 insider transaction
RUBIN PAUL D sold 7,433 shares of BioAge Labs, Inc. at $18.75 per share, a transaction worth $139.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.